Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

BACKGROUND: A safe and effective vaccine for the prevention of human immunodeficiency virus type 1 (HIV-1) infection is a global priority. We tested the efficacy of a DNA prime–recombinant adenovirus type 5 boost (DNA/rAd5) vaccine regimen in persons at increased risk for HIV-1 infection in the Unit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hammer, Scott M., Sobieszczyk, Magdalena E., Janes, Holly, Karuna, Shelly T., Mulligan, Mark J., Grove, Doug, Koblin, Beryl A., Buchbinder, Susan P., Keefer, Michael C., Tomaras, Georgia D., Frahm, Nicole, Hural, John, Anude, Chuka, Graham, Barney S., Enama, Mary E., Adams, Elizabeth, DeJesus, Edwin, Novak, Richard M., Frank, Ian, Bentley, Carter, Ramirez, Shelly, Fu, Rong, Koup, Richard A., Mascola, John R., Nabel, Gary J., Montefiori, David C., Kublin, James, McElrath, M. Juliana, Corey, Lawrence, Gilbert, Peter B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4030634/
https://ncbi.nlm.nih.gov/pubmed/24099601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1310566
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados